COVID-19 guidance

Navigating the ongoing pandemic

Our community has faced enormous changes and challenges caused by the global pandemic.

While the consideration of COVID as a global health emergency may be ending, the virus continues to spread and evolve, and remains a threat to public health. It is important for those living with scleroderma or a related condition to continue to maintain a reasonable level of caution.

The Foundation’s Medical and Scientific Advisory Board recommends reviewing the current Centers for Disease Control and Prevention and American College of Rheumatology data and recommendations.

The National Scleroderma Foundation encourages appropriate vaccines and treatments to protect individuals within the scleroderma community from the serious complications that can result from COVID-19. Individuals should work with their medical team to ensure appropriate care. We are sharing important information from federal public health officials related to the treatment of COVID-19, that is supported by the National Scleroderma Foundation’s Medical & Scientific Advisory Board. We encourage individuals to get or remain current on their COVID-19 vaccinations.

Updated: May 8, 2023.

Disclaimer: The National Scleroderma Foundation in no way endorses any drugs, treatments, clinical trials or studies referenced in this email.  Information is provided to keep the readers informed.  Because the manifestations and severity of scleroderma vary among individuals, personalized medical management is essential.  Therefore, it is strongly recommended that all drugs and treatments be discussed with the reader’s physician for proper evaluation and treatment.